Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The Stock for 1999(Polymedica)PLMD(Medical Supply Co.) -- Ignore unavailable to you. Want to Upgrade?

To: Sam who wrote (2821)	9/3/1999 7:58:00 PM
From: Abuckatatime	Read Replies (1) \| Respond to of 3414

S3 filing. Common stock offered by PolyMedica...... 2,250,000 shares Common stock offered by selling shareholders............................ 650,000 shares Common stock to be outstanding after this offering........................... 12,457,157 shares The net proceeds from the sale of the 2,250,000 shares of common stock offered by us will be approximately $54,782,500 at the assumed public offering price of $26.00 per share, after deducting the underwriting discount and estimated offering expenses payable by us. We will not receive any proceeds from the sale of shares by the selling shareholders. We intend to use $20.0 million of the net proceeds of this offering to retire all of the Guaranteed Senior Secured Notes due January 31, 2003 held by John Hancock Mutual Life Insurance Company and Barnett & Co. These notes bear interest at the rate of 10.90% per annum. In addition, we will pay approximately $1.6 million as an early payment premium. We will use the balance of the net proceeds of this offering for working capital and general corporate purposes. We have discussions on an ongoing basis regarding possible acquisitions or investments in businesses or products that are complementary to our business. Although we may use a portion of the net proceeds for these kinds of investments, there are no current agreements or commitments in this regard. We may, however, change the allocation of these proceeds in response to developments or changes that affect our business or our industry. Pending use of the net proceeds for the above purposes, we plan to invest such funds in short-term, investment grade, interest-bearing securities. Institutional Selling Stockholders John Hancock Mutual Life Insurance Company Barnett & Co. Non-Institutional Selling Stockholders Steven J. Lee Arthur A. Siciliano Eric G. Walters Daniel F. Bernstein